南京科佰生物科技有限公司官方网站欢迎您的光临！
免费咨询热线： 4008-750-250
科研细胞
药靶细胞
标准品
NGS靶向捕获探针
AI-Edigene® EML4(E18)-ALK(E20) V2 Fusion
| CBP20196R |
| Format | RNA |
| Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor activity in mouse models (PMID: 19064915, PMID: 17625570). EML4-ALK fusions have been associated with non-small cell lung cancer (PMID: 26755435). |
| Technical Data | |
| Left Gene | EML4 |
| Left Breakpoint | chr2:42543844:+ |
| Right Gene | ALK |
| Right Breakpoint | chr2:29446566:- |
| Cosmic ID | COSF488 |
| Buffer | RNase-free H2O |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | -80℃ |
| Expiry | 12 months from the date of manufacture |
扫一扫，关注我们公众号
Copyright ©2021 www.cobioer.com All Rights Reserved. 南京科佰生物科技有限公司版权所有 苏ICP备13038923号